ATE94392T1 - In der behandlung von oestrogeninsuffizienz zu verwendende zusammensetzung. - Google Patents

In der behandlung von oestrogeninsuffizienz zu verwendende zusammensetzung.

Info

Publication number
ATE94392T1
ATE94392T1 AT87810103T AT87810103T ATE94392T1 AT E94392 T1 ATE94392 T1 AT E94392T1 AT 87810103 T AT87810103 T AT 87810103T AT 87810103 T AT87810103 T AT 87810103T AT E94392 T1 ATE94392 T1 AT E94392T1
Authority
AT
Austria
Prior art keywords
treatment
oestrogenic
insufficiency
composition
compound
Prior art date
Application number
AT87810103T
Other languages
English (en)
Inventor
Roger Boissoneault
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Application granted granted Critical
Publication of ATE94392T1 publication Critical patent/ATE94392T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/34—Gestagens

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Dental Preparations (AREA)
AT87810103T 1986-02-27 1987-02-23 In der behandlung von oestrogeninsuffizienz zu verwendende zusammensetzung. ATE94392T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US83426386A 1986-02-27 1986-02-27
EP87810103A EP0235090B1 (de) 1986-02-27 1987-02-23 In der Behandlung von Östrogeninsuffizienz zu verwendende Zusammensetzung

Publications (1)

Publication Number Publication Date
ATE94392T1 true ATE94392T1 (de) 1993-10-15

Family

ID=25266516

Family Applications (1)

Application Number Title Priority Date Filing Date
AT87810103T ATE94392T1 (de) 1986-02-27 1987-02-23 In der behandlung von oestrogeninsuffizienz zu verwendende zusammensetzung.

Country Status (12)

Country Link
EP (1) EP0235090B1 (de)
JP (1) JP2942560B2 (de)
AT (1) ATE94392T1 (de)
AU (1) AU599082B2 (de)
CA (1) CA1300017C (de)
DE (1) DE3787386T2 (de)
DK (1) DK174892B1 (de)
ES (1) ES2059403T3 (de)
HK (1) HK182795A (de)
MY (1) MY101855A (de)
NL (1) NL300004I1 (de)
ZA (1) ZA87332B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE61236B1 (en) † 1986-07-15 1994-10-19 American Home Prod Combination dosage form for pre-menopausal women
HUT52382A (en) * 1988-03-14 1990-07-28 Sandoz Ag Process for producing pharmaceutical compositions comprising as active ingredient unsubstituted progestin in 19-position and estrogen in the given case
US5053227A (en) * 1989-03-22 1991-10-01 Cygnus Therapeutic Systems Skin permeation enhancer compositions, and methods and transdermal systems associated therewith
US4973468A (en) * 1989-03-22 1990-11-27 Cygnus Research Corporation Skin permeation enhancer compositions
US5059426A (en) * 1989-03-22 1991-10-22 Cygnus Therapeutic Systems Skin permeation enhancer compositions, and methods and transdermal systems associated therewith
AU640112B2 (en) * 1989-11-03 1993-08-19 Warner-Lambert Company Estrogen and progestogen containing oral dosage forms
US5591753A (en) * 1994-01-28 1997-01-07 Eli Lilly And Company Combination treatment for osteoporosis
FR2754179B1 (fr) 1996-10-08 1998-12-24 Theramex Nouvelle composition hormononale et son utilisation
WO2001030356A1 (fr) 1999-10-25 2001-05-03 Laboratoire Theramex Composition hormonale a base d'un progestatif et d'un estrogene et son utilisation

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU582540B2 (en) * 1983-08-05 1989-04-06 Pre Jay Holdings Ltd. A method of hormonal treatment of perimenopausal, menopausal and post-menopausal disorders and multi-preparation pack therefor

Also Published As

Publication number Publication date
MY101855A (en) 1992-01-31
DK99987D0 (da) 1987-02-26
DE3787386T2 (de) 1994-05-05
ES2059403T3 (es) 1994-11-16
DK99987A (da) 1987-08-28
EP0235090B1 (de) 1993-09-15
DK174892B1 (da) 2004-01-26
HK182795A (en) 1995-12-08
DE3787386D1 (de) 1993-10-21
AU6913087A (en) 1987-09-03
NL300004I1 (nl) 2000-04-03
JPS62205024A (ja) 1987-09-09
EP0235090A1 (de) 1987-09-02
AU599082B2 (en) 1990-07-12
CA1300017C (en) 1992-05-05
JP2942560B2 (ja) 1999-08-30
ZA87332B (en) 1987-08-26

Similar Documents

Publication Publication Date Title
ATE104854T1 (de) Pharmazeutische zusammensetzung zur behandlung von osteoporose.
PH23432A (en) Tetrahydronaphthaline and indane derivatives and pharmaceutical composition containing said compounds
DE3689974D1 (de) Arzneimittel zur Behandlung von Emesis.
ATE38232T1 (de) Metallocene und photopolymerisierbare zusammensetzung, enthaltend diese metallocene.
EP0257786A3 (en) Dosage form for delivering acid sensitive beneficial agent
IT1211936B (it) Chetoni triciclici,procedimento per prepararli e composizioni farmaceutiche che li contengono
EG18379A (en) Novel pharmacological compounds
BR8706373A (pt) Mistura liquida de fotoiniciador e composicao fotoendurecivel
ATE55695T1 (de) Verwendung von defibrotid zur herstellung pharmazeutischer zusammensetzungen zur behandlung peripherer arteriopathien.
ATE94392T1 (de) In der behandlung von oestrogeninsuffizienz zu verwendende zusammensetzung.
DE3583765D1 (de) Hydantoinderivate und diese enthaltende pharmazeutische zusammensetzungen.
DE3686022D1 (de) Monosaccharide enthaltende zusammensetzung zum heilen von wunden.
JPS5328133A (en) Novel compound having lipidddepleting activity in blood*process for preparation thereof and pharmaceutical composition containing these
JPS5555200A (en) Steroid compound and medicine composition
FR2598617B1 (fr) Composition pharmaceutique
DK464483A (da) Fremgangsmaade til fremstilling af et farmaceutisk praeparat indeholdende et fibrinolytisk middel
DE3683286D1 (de) Anthrachinonverbindungen und fluessigkristallzusammensetzung, die diese enthalten.
FR2609392B1 (fr) Compositions pharmaceutiques contenant des pyranoquinoleines
ES2016376B3 (es) Acido n,n-bis-(4-fluorofenil) carbamoilacetohidroxamico y composicion farmaceutica que lo contiene.
IE41296L (en) 2', 3'-DIHYDROESTRA-1, 3, 5(10)-TRIENO-(16Ó, 17Ó-b)¹FURAN-17ß-OLS.
ATE87482T1 (de) Pharmazeutische praeparate zur behandlung von zereberalen psycho-organischen syndromen.
EP0244822A3 (en) Balsamic fragrance composition and process for preparation
IT1197929B (it) Composizione perossidiche liquide
DE3763141D1 (de) Pharmazeutische zusammensetzungen zur behandlung des charcot-syndroms.
DE3785367D1 (de) Eine in einer photopolymerisierbaren verbindung dispergiertes silberhalogenid enthaltende zusammensetzung und diese zusammensetzung enthaltendes lichtempfindliches material.

Legal Events

Date Code Title Description
REN Ceased due to non-payment of the annual fee